<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter>Zhou G</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4> We aimed to evaluate the indeterminate rate of interferon gamma release assays (IGRAs) in the detection of latent tuberculosis infection (LTBI). &lt;h4>Methods&lt;/h4> On 15 November 2022, we searched the PubMed® (National Library of Medicine, Bethesda, MD, USA), Embase® (Elsevier, Amsterdam, the Netherlands), and Cochrane Library databases in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two investigators independently extracted the study data and assessed their quality using a modified quality assessment of diagnostic accuracy studies (i.e., QUADAS-2) tool. A random-effects model was used to calculate pooled results. &lt;h4>Results&lt;/h4> We included 403 studies involving 486,886 individuals and found that the pooled </pubmed_abstract><journal>Frontiers in immunology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10225525</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis</pubmed_title><pmcid>PMC10225525</pmcid><pubmed_authors>Xia Y</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Luo Q</pubmed_authors><pubmed_authors>Cai S</pubmed_authors><pubmed_authors>He J</pubmed_authors><pubmed_authors>Guo X</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Song C</pubmed_authors><pubmed_authors>Zhou G</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Luo S</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis</name><description>&lt;h4>Objectives&lt;/h4> We aimed to evaluate the indeterminate rate of interferon gamma release assays (IGRAs) in the detection of latent tuberculosis infection (LTBI). &lt;h4>Methods&lt;/h4> On 15 November 2022, we searched the PubMed® (National Library of Medicine, Bethesda, MD, USA), Embase® (Elsevier, Amsterdam, the Netherlands), and Cochrane Library databases in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two investigators independently extracted the study data and assessed their quality using a modified quality assessment of diagnostic accuracy studies (i.e., QUADAS-2) tool. A random-effects model was used to calculate pooled results. &lt;h4>Results&lt;/h4> We included 403 studies involving 486,886 individuals and found that the pooled </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-19T02:37:29.942Z</modification><creation>2025-04-19T02:37:29.942Z</creation></dates><accession>S-EPMC10225525</accession><cross_references/></HashMap>